Dofetilide
Dofetilide is a class III antiarrhythmic agent that is prescribed to treat irregular heartbeats, specifically atrial fibrillation and atrial flutter. It is marketed under the brand name Tikosyn by Pfizer, and is available in capsule form.
Pharmacology[edit | edit source]
Dofetilide works by selectively blocking the rapid component of the delayed rectifier outward potassium current (IKr) in the heart. This action prolongs repolarization of the cardiac action potential, which leads to a lengthening of the QT interval on the electrocardiogram. Dofetilide does not affect the inward sodium channel, and it is therefore not classified as a class Ia antiarrhythmic agent.
Clinical Use[edit | edit source]
Dofetilide is used for the maintenance of sinus rhythm in patients with atrial fibrillation or atrial flutter. It is also used for the conversion of atrial fibrillation and atrial flutter to sinus rhythm. However, it is not effective in converting ventricular tachycardia or ventricular fibrillation to sinus rhythm.
Side Effects[edit | edit source]
The most serious side effect of dofetilide is Torsades de Pointes, a potentially fatal ventricular arrhythmia. Other side effects include headache, chest pain, and dizziness. Because of the risk of Torsades de Pointes, dofetilide is only available through a restricted distribution program called the TIKOSYN Risk Evaluation and Mitigation Strategy (REMS) Program.
Drug Interactions[edit | edit source]
Dofetilide is primarily eliminated by the kidneys, and drugs that interfere with renal function can increase the risk of dofetilide toxicity. These include diuretics, ACE inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Dofetilide should not be used with drugs that prolong the QT interval, such as amiodarone, sotalol, and certain antipsychotics.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This cardiovascular system article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
